MONDRIAN INVESTMENT PARTNERS LTD
Q3 2026 Form 13-F
LONDON
CIK 0001317724
· CRD 107432
· SEC-registered investment adviser
Holdings reported by
PERSONAL CFO SOLUTIONS LLC since Q3 2023
$5.4B Reported Value Total
MONDRIAN INVESTMENT PARTNERS LIMITED reports 118 total accounts under management (AUM). There are 118 discretionary accounts valued at $49,307,964,822, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
39 funds
· $5.8B gross asset value
Other: $5.8B
Source: Form ADV filed 2026-04-01
Reported value
$5.4B
Quarter over quarter
+4.1%
Holdings
135
Top-10 concentration
54.5%
Filing Structure
Reports holdings for
- Alaska Permanent Fund Corp · File #028-20231 · Q1 2024 – Q1 2026 · declared by one filing
- Desjardins Global Asset Management Inc · File #028-21533 · Q2 2024 – Q2 2025 · declared by one filing
- Lincoln Investment Advisors Corp · File #028-15854 · Q1 2024 – Q1 2025 · declared by one filing
- Russell Investments Group Ltd · File #028-17598 · Q1 2017 – Q4 2019 · declared by one filing
- RUSSELL FRANK CO · File #028-01190 · Q3 2014 – Q4 2016 · declared by one filing
Holdings reported by
- PERSONAL CFO SOLUTIONS LLC · since Q3 2023 · declared by one filing
- Russell Investments Group Ltd · Q1 2024 – Q1 2025 · declared by one filing
Key People
Form ADV owners & control persons
Elizabeth Anne Desmond
CHAIRMAN
Clive Ashley Gillmore
CHIEF EXECUTIVE OFFICER / GROUP CHIEF INVESTMENT OFFICER / DIRECTOR
Ormala Krishnan
CHIEF INVESTMENT OFFICER, SMALL CAP EQUITIES / DIRECTOR
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | October 23, 2026 |
| Form | 13F-HR |
| Reported value | $5.4B |
| Positions | 135 |
| Change in reported value | -16.8% |
| New positions | 34 |
| Exited positions | 11 |
| Position turnover | 30.8% |
| Top-10 concentration | 54.5% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Oct 23, 2026
|
135 | $5.4B |
|
Q2 2026 13F
Filed Jul 30, 2026
|
111 | $6.5B |
|
Q1 2026 13F
Filed Apr 29, 2026
|
103 | $6.7B |
|
Q4 2025 13F
Filed Feb 9, 2026
|
101 | $6.1B |
|
Q3 2025 13F
Filed Nov 7, 2025
|
96 | $6.0B |
|
Q1 2025 13F
Filed May 13, 2025
|
98 | $5.8B |
|
Q4 2024 13F
Filed Feb 10, 2025
|
100 | $6.1B |
|
Q3 2024 13F
Filed Nov 5, 2024
|
100 | $6.6B |
|
Q2 2024 13F
Filed Aug 12, 2024
|
96 | $6.5B |
|
Q1 2024 13F
Filed May 7, 2024
|
98 | $7.3B |
|
Q4 2023 13F
Filed Feb 13, 2024
|
98 | $6.3B |
|
Q3 2023 13F
Filed Nov 6, 2023
|
91 | $4.9B |
|
Q2 2023 13F
Filed Aug 10, 2023
|
88 | $5.0B |
|
Q1 2023 13F
Filed May 9, 2023
|
90 | $4.5B |
|
Q4 2022 13F
Filed Feb 3, 2023
|
92 | $4.5B |
|
Q3 2022 13F
Filed Oct 21, 2022
|
83 | $4.6B |
|
Q2 2022 13F
Filed Aug 9, 2022
|
79 | $4.8B |
|
Q1 2022 13F
Filed May 5, 2022
|
123 | $4.9B |
|
Q4 2021 13F
Filed Feb 9, 2022
|
129 | $5.1B |
34 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | YUMC Yum China HK | $874.0M | 16.21% |
| 2 | SONY Sony ADR | $294.5M | 5.46% |
| 3 | LYG Lloyds Bank ADR | $266.4M | 4.94% |
| 4 | SAN BSCH ADR | $259.3M | 4.81% |
| 5 | GSK GSK PLC ADR | $239.2M | 4.44% |
| 6 | BTI BATS ADR | $237.1M | 4.4% |
| 7 | SNY Sanofi ADR | $233.0M | 4.32% |
| 8 | PHG Philips ADR | $192.6M | 3.57% |
| 9 | BP BP Plc ADR | $174.9M | 3.24% |
| 10 | PBR Petrobras ADR | $168.5M | 3.13% |
| 11 | HLN Haleon ADR | $158.7M | 2.94% |
| 12 | MSFT Microsoft Corp | $149.6M | 2.78% |
| 13 | SHEL Shell ADR | $123.4M | 2.29% |
| 14 | VALE Vale SA ADR | $110.8M | 2.06% |
| 15 | TMO Thermo Fisher | $106.3M | 1.97% |
| 16 | GOOGL Alphabet CL A | $100.6M | 1.87% |
| 17 | SCHW Charles Schwab | $96.0M | 1.78% |
| 18 | META Meta Platforms | $85.8M | 1.59% |
| 19 | MRK Merck | $84.9M | 1.57% |
| 20 | CRM Salesforce | $81.5M | 1.51% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.